520 filings
Page 13 of 26
425
hi9r1a2k fyfqz3yii0
20 Mar 20
Business combination disclosure
12:00am
8-K
nmsozpp2jdsqntq
19 Mar 20
OpGen Provides Update on Shareholder Proxy Voting in Relation to the Business Combination with Curetis
4:22pm
425
i61a1 6xrvxsu7w
19 Mar 20
Business combination disclosure
4:20pm
424B5
iblc 27l8lkpltdmi2
18 Mar 20
Prospectus supplement for primary offering
12:00am
425
erj56hopwy9z2m6
18 Mar 20
Business combination disclosure
12:00am
8-K
r5h2jzlk
16 Mar 20
OpGen Provides Update on Curetis Now Offering BGI’s CE-IVD Rapid Test Kit for Coronavirus in Europe
4:09pm
425
fso1ebo5l cvxglf
16 Mar 20
Business combination disclosure
4:07pm
425
o8eickfu7he 3nt
12 Mar 20
Business combination disclosure
9:08am
8-K
ib5sdx
10 Mar 20
Curetis N.V. Shareholders Approve Planned Business Combination with OpGen
5:29pm
425
e5r335c owkz
10 Mar 20
Business combination disclosure
5:27pm
425
g1a98ymby
3 Mar 20
Business combination disclosure
5:29pm
8-K
nml8q tb6g
28 Feb 20
Entry into a Material Definitive Agreement
12:00am
8-K
5a4efxb 4qwqtzgv4hva
20 Feb 20
OpGen Provides Update on Curetis Preliminary, Unaudited 2019 Condensed Combined Key Financials and Business Update
5:22pm
425
764fjbwiscgj pt
20 Feb 20
Business combination disclosure
5:20pm
8-K
73rgh7kogc
12 Feb 20
OpGen Announces Preliminary Unaudited Revenue for Fiscal 2019 and Provides Business Update
4:43pm
8-K
swzlpd
12 Feb 20
Entry into a Material Definitive Agreement
9:25am
424B5
nc6sa65
12 Feb 20
Prospectus supplement for primary offering
12:00am
EFFECT
a6uqgyyg
10 Feb 20
Notice of effectiveness
12:15am
CORRESP
ox1mlzm0rtik
6 Feb 20
Correspondence with SEC
12:00am